MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$56,697K
EPS
-$0.93
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development-Related Party
1,982 5,549* 5,817 2,932
Research and development-Nonrelated Party
45,518 33,092* 27,158 21,866
General and administrative
12,742 8,127* 7,701 7,220
Total operating expenses
60,242 46,767 40,676 32,018
Loss from operations
-60,242 -46,767* -40,676 -32,018
Interest income
4,083 4,269 4,386 4,682
Total other income
4,083 4,269* 4,386 4,682
Net loss before income taxes
-56,159 -42,498* -36,290 -27,336
Income tax expense
52 79* 40 52
Net loss
-56,211 -42,577* -36,330 -27,388
Unrealized loss on marketable securities, net of tax
-486 651 -136 -
Total other comprehensive loss
-486 651* -136 -
Total comprehensive loss
-56,697 -41,926 -36,466 -
Basic EPS
-0.93 -0 -0.67 -0.5
Diluted EPS
-0.93 -0 -0.67 -0.5
Basic Average Shares
60,717,041 163,921,584,906 54,563,864 54,539,230
Diluted Average Shares
60,717,041 163,921,584,906 54,563,864 54,539,230
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveloss-$56,697K Net loss-$56,211K Total othercomprehensive loss-$486K Interest income$4,083K Net loss beforeincome taxes-$56,159K Income tax expense$52K Unrealized loss onmarketable securities, net...-$486K Total other income$4,083K Loss from operations-$60,242K Total operatingexpenses$60,242K Research anddevelopment-Nonrelated Party$45,518K General andadministrative$12,742K Research anddevelopment-Related Party$1,982K

Bicara Therapeutics Inc. (BCAX)

Bicara Therapeutics Inc. (BCAX)